ATC code N Nervous system is a section of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1][2][3][4]
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QN.[5] ATCvet codes without corresponding human ATC codes are cited with the leading Q in the following list.
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
N Nervous system |
---|
N01 Anesthetics |
N02 Analgesics |
N03 Antiepileptics |
N04 Anti-parkinson drugs |
N05 Psycholeptics |
N06 Psychoanaleptics |
N07 Other nervous system drugs |
ATCvet only |
QN51 Products for animal euthanasia |
|
Major chemical drug groups – based upon the Anatomical Therapeutic Chemical Classification System | |
---|---|
gastrointestinal tract / metabolism (A) | |
blood and blood forming organs (B) | |
cardiovascular system (C) | |
skin (D) | |
genitourinary system (G) | |
endocrine system (H) | |
infections and infestations (J, P, QI) | |
malignant disease (L01–L02) | |
immune disease (L03–L04) | |
muscles, bones, and joints (M) | |
brain and nervous system (N) |
|
respiratory system (R) | |
sensory organs (S) | |
other ATC (V) | |
Inhalational | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Injection |
| ||||||||||||||
|
Esters by acid |
| ||||||
---|---|---|---|---|---|---|---|
Amides | |||||||
Combinations | |||||||
|
Antimigraine preparations (N02C) | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Analgesic/abortive |
| ||||||||||||||||
Prophylactic |
| ||||||||||||||||
|
GABAergics |
| ||||||
---|---|---|---|---|---|---|---|
Channel modulators |
| ||||||
Others |
| ||||||
|
Dopaminergics |
| ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Anticholinergics | |||||||||||
Others | |||||||||||
|
D1-like |
| ||||||
---|---|---|---|---|---|---|---|
D2-like |
| ||||||
Typical |
|
---|---|
Disputed | |
Atypical | |
Others |
|
|
5-HT1AR agonists | |
---|---|
GABAAR PAMs |
|
Gabapentinoids (α2δ VDCC blockers) | |
Antidepressants |
|
Sympatholytics (Antiadrenergics) |
|
Others | |
|
GABAA |
| ||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
GABAB | |||||||||||||||||||||||||
H1 |
| ||||||||||||||||||||||||
α2-Adrenergic | |||||||||||||||||||||||||
5-HT2A |
| ||||||||||||||||||||||||
Melatonin | |||||||||||||||||||||||||
Orexin | |||||||||||||||||||||||||
α2δ VDCC | |||||||||||||||||||||||||
Others |
|
| |||||||||||||||||||||
| |||||||||||||||||||||
| |||||||||||||||||||||
| |||||||||||||||||||||
|
N06BA Centrally acting sympathomimetics | |||||||||
---|---|---|---|---|---|---|---|---|---|
N06BC Xanthine derivatives | |||||||||
N06BX Other psychostimulants and nootropics | |||||||||
|
AChE inhibitor medications | |
---|---|
Other medications | |
Experimental BACE inhibitors |
|
Treatment of drug dependence (N07B) | |
---|---|
Nicotine dependence | |
Alcohol dependence | |
Opioid dependence | |
Benzodiazepine dependence |